Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials
Takao Ohki
, Hiroyoshi Yokoi
, Kimihiko Kichikawa
, Takeshi Kimura
, Scott A. Snyder
, Anthony O. Ragheb
, Erin E. O'Leary
, Michael R. Jaff
, Gary M. Ansel
,
Michael D. Dake
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Clinical Trial
100%
Randomized Controlled Trial
100%
Drug-Eluting Stent
100%
Percutaneous Transluminal Angioplasty
57%
Paclitaxel
28%
Subgroup Analysis
28%
Stent Fracture
28%
Target Lesion Revascularization
28%
Artery
14%
Arteriosclerosis Obliterans
14%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Clinical Trial
100%
Randomized Controlled Trial
100%
Stent Fracture
100%
Peripheral Occlusive Artery Disease
50%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Randomized Controlled Trial
100%
Patency
100%
Keyphrases
Multinational Clinical Trials
100%
Immunology and Microbiology
Target Lesion Revascularization
100%